MOLLY SNYDER: Open Payments
NPI 1023634201 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$467 in 15 payments from 7 companies in 2025. Trend: 2023 $826 · 2024 $1,329 · 2025 $467
Food & beverage: $372Education: $95
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $147 |
| Regeneron Healthcare Solutions, Inc. | 1 | $95 |
| Novartis Pharmaceuticals Corporation | 4 | $87 |
| CSL Behring | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Genentech USA, Inc. | 1 | $25 |
| Grifols USA, LLC | 1 | $22 |
Products named: DUPIXENT, TEZSPIRE, Hizentra, Xolair, Rhapsido, Xembify, FASENRA, HYQVIA.
Industry payments across TN — which companies pay providers there.
